Rxivist logo

Author: Andrew Owen

Rankings

  • All-time downloads: 27,315 (rank: 7,999 (tie) )
  • Categories:
    • genetics: 287 (rank: 39,068 (tie) )
    • immunology: 1,392 (rank: 9,996 (tie) )
    • infectious diseases: 4,926 (rank: 10,650 (tie) )
    • microbiology: 9,180 (rank: 1,950 )
    • pathology: 1,078 (rank: 1,441 (tie) )
    • pharmacology and therapeutics: 8,179 (rank: 50 (tie) )
    • pharmacology and toxicology: 1,846 (rank: 702 (tie) )
    • respiratory medicine: 427 (rank: 2,065 (tie) )

Downloads per author, site-wide

Preprints

Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate target site concentrations derived from their established human pharmacokinetics

pharmacology and therapeutics more details view paper
  • Downloaded 4,651 times
  • Download rankings, all-time:
    • Site-wide: 2,950
    • In pharmacology and therapeutics: 9
  • Year to date:
    • Site-wide: 9,543
  • Since beginning of last month:
    • Site-wide: 14,835

Remdesivir-Ivermectin combination displays synergistic interaction with improved in vitro antiviral activity against SARS-CoV-2

microbiology more details view paper
  • Downloaded 3,607 times
  • Download rankings, all-time:
    • Site-wide: 4,206
    • In microbiology: 286
  • Year to date:
    • Site-wide: 1,036
  • Since beginning of last month:
    • Site-wide: 8,022

Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis

infectious diseases more details view paper
  • Downloaded 3,156 times
  • Download rankings, all-time:
    • Site-wide: 5,100
    • In infectious diseases: 983
  • Year to date:
    • Site-wide: 12,275
  • Since beginning of last month:
    • Site-wide: 24,826

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a phase 1, dose-escalating, randomised controlled study

pharmacology and therapeutics more details view paper
  • Downloaded 2,959 times
  • Download rankings, all-time:
    • Site-wide: 5,608
    • In pharmacology and therapeutics: 20
  • Year to date:
    • Site-wide: 1,195
  • Since beginning of last month:
    • Site-wide: 225

The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2

microbiology more details view paper
  • Downloaded 2,560 times
  • Download rankings, all-time:
    • Site-wide: 6,929
    • In microbiology: 418
  • Year to date:
    • Site-wide: 11,148
  • Since beginning of last month:
    • Site-wide: 11,871

Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19.

microbiology more details view paper
  • Downloaded 1,679 times
  • Download rankings, all-time:
    • Site-wide: 12,955
    • In microbiology: 752
  • Year to date:
    • Site-wide: 8,421
  • Since beginning of last month:
    • Site-wide: 8,204

Single-dose immunisation with a multimerised SARS-CoV-2 receptor binding domain (RBD) induces an enhanced and protective response in mice

immunology more details view paper
  • Downloaded 1,392 times
  • Download rankings, all-time:
    • Site-wide: 17,324
    • In immunology: 607
  • Year to date:
    • Site-wide: 3,305
  • Since beginning of last month:
    • Site-wide: 8,739

Modelling of Systemic versus Pulmonary Chloroquine Exposure in Man for COVID-19 Dose Selection

infectious diseases more details view paper
  • Downloaded 1,115 times
  • Download rankings, all-time:
    • Site-wide: 24,221
    • In infectious diseases: 2,270
  • Year to date:
    • Site-wide: 57,690
  • Since beginning of last month:
    • Site-wide: 59,694

Viral neuroinvasion and neurotropism without neuronal damage in the hACE2 mouse model of COVID-19

pathology more details view paper
  • Downloaded 1,078 times
  • Download rankings, all-time:
    • Site-wide: 25,527
    • In pathology: 114
  • Year to date:
    • Site-wide: 4,798
  • Since beginning of last month:
    • Site-wide: 17,314

Development of a highly sensitive bioanalytical assay for the quantification of favipiravir.

pharmacology and toxicology more details view paper
  • Downloaded 806 times
  • Download rankings, all-time:
    • Site-wide: 39,062
    • In pharmacology and toxicology: 223
  • Year to date:
    • Site-wide: 7,538
  • Since beginning of last month:
    • Site-wide: 38,933

Naturally-acquired immunity in Syrian Golden Hamsters provides protection from re-exposure to emerging heterosubtypic SARS-CoV-2 variants B.1.1.7 and B.1.351

microbiology more details view paper
  • Downloaded 772 times
  • Download rankings, all-time:
    • Site-wide: 41,578
    • In microbiology: 2,490
  • Year to date:
    • Site-wide: 8,039
  • Since beginning of last month:
    • Site-wide: 42,731

Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5'-triphosphate exposure to support posology for SARS-CoV-2

infectious diseases more details view paper
  • Downloaded 655 times
  • Download rankings, all-time:
    • Site-wide: 52,272
    • In infectious diseases: 3,386
  • Year to date:
    • Site-wide: 10,447
  • Since beginning of last month:
    • Site-wide: 17,072

An open label, adaptive, phase 1 trial of high-dose oral nitazoxanide in healthy volunteers: an antiviral candidate for SARS-CoV-2

pharmacology and therapeutics more details view paper
  • Downloaded 569 times
  • Download rankings, all-time:
    • Site-wide: 62,584
    • In pharmacology and therapeutics: 74
  • Year to date:
    • Site-wide: 13,033
  • Since beginning of last month:
    • Site-wide: 4,534

Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variants.

microbiology more details view paper
  • Downloaded 562 times
  • Download rankings, all-time:
    • Site-wide: 63,635
    • In microbiology: 4,018
  • Year to date:
    • Site-wide: 13,308
  • Since beginning of last month:
    • Site-wide: 101,690

TITLE: Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics

respiratory medicine more details view paper
  • Downloaded 427 times
  • Download rankings, all-time:
    • Site-wide: 86,631
    • In respiratory medicine: 171
  • Year to date:
    • Site-wide: 20,331
  • Since beginning of last month:
    • Site-wide: 1,395

Evaluation of intranasal nafamostat or camostat for SARS-CoV-2 chemoprophylaxis in Syrian golden hamsters

pharmacology and toxicology more details view paper
  • Downloaded 418 times
  • Download rankings, all-time:
    • Site-wide: 88,460
    • In pharmacology and toxicology: 585
  • Year to date:
    • Site-wide: 21,045
  • Since beginning of last month:
    • Site-wide: 40,506

Optimisation and validation of a sensitive bioanalytical method for niclosamide.

pharmacology and toxicology more details view paper
  • Downloaded 406 times
  • Download rankings, all-time:
    • Site-wide: 90,990
    • In pharmacology and toxicology: 601
  • Year to date:
    • Site-wide: 21,970
  • Since beginning of last month:
    • Site-wide: 30,255

N-acetyltransferase 2 genotypes amongst ulu Speaking South Africans and isoniazid / N-acetyl-isoniazid pharmacokinetics during ant-tuberculosis treatment

genetics more details view paper
  • Downloaded 287 times
  • Download rankings, all-time:
    • Site-wide: 119,796
    • In genetics: 4,871
  • Year to date:
    • Site-wide: 92,328
  • Since beginning of last month:
    • Site-wide: 56,199

Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research.

pharmacology and toxicology more details view paper
  • Downloaded 216 times
  • Download rankings, all-time:
    • Site-wide: 138,470
    • In pharmacology and toxicology: 1,124
  • Year to date:
    • Site-wide: 53,013
  • Since beginning of last month:
    • Site-wide: 55,252

PanLingua

News